Search
Hualan Biological Inc.: Its Subsidiary Intends to Boost Capital of Natural Constant by RMB 205 Million
20 hour ago /
Read about 0 minute
Author：小编
Hualan Biological Inc. has made an announcement stating that its wholly-owned subsidiary, Hainan Lingqing Digital Intelligence Pharmaceutical Technology Co., Ltd., intends to augment the capital of Wuxi Natural Constant Technology Co., Ltd. by RMB 205 million, utilizing its in-house funds. Upon completion of this capital increase, Hainan Lingqing will secure a 34.17% equity stake in Natural Constant, thereby emerging as its principal shareholder. This strategic investment is geared towards optimizing Hualan Biological Inc.'s positioning within the AI-driven pharmaceutical landscape, fostering the expansion of its AI-powered pharmaceutical operations, and fortifying the company's overall core competitiveness and long-term growth prospects.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
